Detalhe da pesquisa
1.
Androgen receptor-regulated circFNTA activates KRAS signaling to promote bladder cancer invasion.
EMBO Rep
; 21(4): e48467, 2020 04 03.
Artigo
Inglês
| MEDLINE | ID: mdl-32052578
2.
Olaparib and enzalutamide synergistically suppress HCC progression via the AR-mediated miR-146a-5p/BRCA1 signaling.
FASEB J
; 34(4): 5877-5891, 2020 04.
Artigo
Inglês
| MEDLINE | ID: mdl-32134529
3.
LncRNA PCAT1 activates AKT and NF-κB signaling in castration-resistant prostate cancer by regulating the PHLPP/FKBP51/IKKα complex.
Nucleic Acids Res
; 47(8): 4211-4225, 2019 05 07.
Artigo
Inglês
| MEDLINE | ID: mdl-30773595
4.
Correction to: Targeting TR4 nuclear receptor suppresses prostate cancer invasion via reduction of infiltrating acrophages with alteration of the TIMP-1/MMP2/MMP9 signals.
Mol Cancer
; 19(1): 97, 2020 05 30.
Artigo
Inglês
| MEDLINE | ID: mdl-32473639
5.
Preclinical studies using miR-32-5p to suppress clear cell renal cell carcinoma metastasis via altering the miR-32-5p/TR4/HGF/Met signaling.
Int J Cancer
; 143(1): 100-112, 2018 07 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29396852
6.
Sorafenib with ASC-J9® synergistically suppresses the HCC progression via altering the pSTAT3-CCL2/Bcl2 signals.
Int J Cancer
; 140(3): 705-717, 2017 Feb 01.
Artigo
Inglês
| MEDLINE | ID: mdl-27668844
7.
Correction: Targeting the unique methylation pattern of androgen receptor (AR) promoter in prostate stem/progenitor cells with 5-aza-2'-deoxycytidine (5-AZA) leads to suppressed prostate tumorigenesis.
J Biol Chem
; 295(48): 16469, 2020 Nov 27.
Artigo
Inglês
| MEDLINE | ID: mdl-33246943
8.
Correction: Differential androgen deprivation therapies with anti-androgens Casodex/bicalutamide or MDV3100/enzalutamide versus anti-androgen receptor ASC-J9® lead to promotion versus suppression of prostate cancer metastasis.
J Biol Chem
; 295(46): 15796, 2020 Nov 13.
Artigo
Inglês
| MEDLINE | ID: mdl-33188084
9.
Correction: Functional domain and motif analyses of androgen receptor coregulator ARA70 and its differential expression in prostate cancer.
J Biol Chem
; 295(50): 17382, 2020 Dec 11.
Artigo
Inglês
| MEDLINE | ID: mdl-33310747
10.
Targeting fatty acid synthase with ASC-J9 suppresses proliferation and invasion of prostate cancer cells.
Mol Carcinog
; 55(12): 2278-2290, 2016 12.
Artigo
Inglês
| MEDLINE | ID: mdl-26894509
11.
Stromal androgen receptor roles in the development of normal prostate, benign prostate hyperplasia, and prostate cancer.
Am J Pathol
; 185(2): 293-301, 2015 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-25432062
12.
Targeting TR4 nuclear receptor suppresses prostate cancer invasion via reduction of infiltrating macrophages with alteration of the TIMP-1/MMP2/MMP9 signals.
Mol Cancer
; 14: 16, 2015 Jan 27.
Artigo
Inglês
| MEDLINE | ID: mdl-25623427
13.
TR4 nuclear receptor promotes prostate cancer metastasis via upregulation of CCL2/CCR2 signaling.
Int J Cancer
; 136(4): 955-64, 2015 Feb 15.
Artigo
Inglês
| MEDLINE | ID: mdl-24975468
14.
Testicular orphan nuclear receptor 4 is associated with the radio-sensitivity of prostate cancer.
Prostate
; 75(14): 1632-42, 2015 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-26178291
15.
Concise review: androgen receptor differential roles in stem/progenitor cells including prostate, embryonic, stromal, and hematopoietic lineages.
Stem Cells
; 32(9): 2299-308, 2014 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-24740898
16.
Proteomic analysis of urethral protein expression in an estrogen receptor α-deficient murine model of stress urinary incontinence.
World J Urol
; 33(10): 1635-43, 2015 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-25577129
17.
Evidence of TGF-ß1 mediated epithelial-mesenchymal transition in immortalized benign prostatic hyperplasia cells.
Mol Membr Biol
; 31(2-3): 103-10, 2014.
Artigo
Inglês
| MEDLINE | ID: mdl-24650126
18.
Abnormal mitochondrial function and impaired granulosa cell differentiation in androgen receptor knockout mice.
Int J Mol Sci
; 16(5): 9831-49, 2015 Apr 30.
Artigo
Inglês
| MEDLINE | ID: mdl-25941928
19.
TR4 nuclear receptor functions as a tumor suppressor for prostate tumorigenesis via modulation of DNA damage/repair system.
Carcinogenesis
; 35(6): 1399-406, 2014 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-24583925
20.
Differential androgen deprivation therapies with anti-androgens casodex/bicalutamide or MDV3100/Enzalutamide versus anti-androgen receptor ASC-J9(R) Lead to promotion versus suppression of prostate cancer metastasis.
J Biol Chem
; 288(27): 19359-69, 2013 Jul 05.
Artigo
Inglês
| MEDLINE | ID: mdl-23687298